Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of ...

Turin strengthens its role in the space economy with the ESA Bass roadshow: a focus on businesses, innovation, space ...

Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with ...

Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria ...

Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program CSU is a chronic skin ...

LLMs-gone-rogue dominated coverage, but had nothing to do with the targeting. Instead, it was choices made by human beings, over many years, that gave us this atrocity ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

HIVE raises $115M to expand data centers while Keel exits Latin America, redirecting funds into HPC and AI as both stocks ...

“Project Hail Mary” directors Phil Lord and Chris Miller recently appeared on the “Happy Sad Confused” podcast and revealed they showed a nearly four-hour cut of their space movie to a group of ...

Learn how to build a comprehensive cryptographic inventory and strengthen quantum‑safe readiness using Microsoft Security ...